PhoenixBio Co., Ltd. (TYO:6190)
Japan · Delayed Price · Currency is JPY 348.00
-3.00 (-0.85%)
Jul 16, 2026, 10:18 AM JST
PhoenixBio Market Cap
PhoenixBio has a market cap or net worth of 1.43 billion as of July 15, 2026. Its market cap has decreased by -7.18% in one year.
Market Cap
1.43B
Enterprise Value
765.64M
Revenue
1.57B
Ranking
n/a
PE Ratio
11.41
Stock Price
348.00
Market Cap Chart
Since March 18, 2016, PhoenixBio's market cap has decreased from 8.06B to 1.43B, a decrease of -82.27%. That is a compound annual growth rate of -15.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 1.43B | -27.48% |
| Dec 30, 2025 | 1.97B | 47.38% |
| Dec 30, 2024 | 1.34B | -23.59% |
| Dec 29, 2023 | 1.75B | -25.42% |
| Dec 30, 2022 | 2.35B | 39.61% |
| Dec 30, 2021 | 1.68B | -13.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PRISM BioLab Co.,LTD | 5.80B |
| Chiome Bioscience | 5.59B |
| Soiken Holdings | 5.55B |
| TMS Co., Ltd. | 4.74B |
| D. Western Therapeutics Institute | 4.71B |
| Kohjin Bio | 4.40B |
| Ribomic | 4.08B |
| Transgenic Group | 3.70B |